Sales and Marketing

Showing 15 posts of 11524 posts found.

Crunch Time: The Impact of Serialisation Requirements on Packaging Operations

March 31, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PCI services

Introduction More than three years have passed since the US federal government signed the Drug Supply Chain Security Act (DSCSA) …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

March 31, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

It’s the end of the week, and the headlines were populated with stand-out stories that proved popular with our readers. …

FDA approves first-ever atopic dermatitis biologic treatment

March 31, 2017 Medical Communications, Sales and Marketing Dupixent, Regeneron, Sanofi, atopic dermatitis, biologic

Sanofi and Regeneron’s Dupixent (dupilumab) has become the first biologic medicine to be approved by the FDA for the treatment …
astrazeneca_sign_sky

AstraZeneca ends month with two pieces of news

March 31, 2017 Medical Communications, Sales and Marketing AstraZeneca, Tagrisso, TerSera Therapeutics, Zoladex

AstraZeneca has ended the month with more positive news on Tagrisso, that had previously been approved in China under its …
giles_platford

Takeda names new President of Europe and Canada Business Unit

March 31, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment

Takeda has named Giles Platford as its new President of Europe and Canada (EUCAN) Business Unit as of 1 April, …
paul-catchpole

Insider Interview: ABPI’s Paul Catchpole discusses NICE’s new fast-track appraisal system

March 30, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Insider Interview, NICE, Paul Catchpole, fast track

Paul Catchpole, Value and Access Director at the Association of the British Pharmaceutical Industry (ABPI), gives his thoughts on the …
fda2outsideweb

Trump’s FDA pick vows to sever past pharma ties to avoid partisanship

March 30, 2017 Medical Communications, Sales and Marketing FDA, Scott Gottlieb, Trump

After much speculation, Donald Trump recently announced his top pick for Commissioner of the FDA as Dr Scott Gottlieb. Gottlieb …

Mylan’s generic of best-selling GSK drug delayed by FDA

March 30, 2017 Sales and Marketing Advair, GSK, Mylan

Mylan’s plan to bring its generic competitor to GSK’s best-selling respiratory drug, Advair, has hit a major snag after it …
roche_close

First treatment for form of MS approved by FDA

March 30, 2017 Sales and Marketing Biogen, Genentech, MS, Roche

In big news for sufferers of MS and the company that developed the drug, Roche subsidiary Genetech, the FDA has …
novartis_outside_1

Novartis investigational CAR-T therapy gets FDA priority review

March 30, 2017 Sales and Marketing CTL019, FDA, Novartis, leukaemia

Novartis’ investigational chimeric antigen receptor T cell (CAR-T) therapy CTL019 (tisagenlecleucel-T) has been awarded has been awarded priority review by …
pharmafocus_april_front_cover

The April 2017 edition of Pharmafocus is available to read online now!

March 29, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, Pharmafocus new issue

From industry reaction to NICE’s new regulatory guidelines to the rising threat of counterfeit medicine, you can read all the …
sanofi_regeneron

Breakthrough eczema drug given FDA approval

March 29, 2017 Research and Development, Sales and Marketing Dupixent, Regeneron, Sanofi

Regeneron and Sanofi have received approval for its eczema treatment, Dupixent, by the FDA. The treatment will be the first …
ludwig_hantson_small

Alexion leadership uncertainty ends as ex-Baxalta CEO steps in

March 28, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alexion, CEO

Alexion had been left in leadership limbo for the beginning of the year, as former CEO and CFO left under …

Renowned scientist Owen N. Witte joins Kite Pharma Board of Directors

March 28, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Kite Pharma has revealed the addition of celebrated bioscientist and researcher Dr Owen N. Witte to its Board of Directors, …
valeant_web

Former Valeant CEO Michael Pearson sues over $30m unpaid shares

March 28, 2017 Manufacturing and Production, Sales and Marketing Michael Pearson, Valeant

Ex-Valeant CEO Michael Pearson is suing his former company over its failure to deliver three million shares he claims he …
The Gateway to Local Adoption Series

Latest content